Company Filing History:
Years Active: 1980
Title: Jan P Carisson: Innovator in Assaying Methods
Introduction
Jan P Carisson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biospecific affinity reactions through his innovative patent. His work has implications for various applications in diagnostics and assay methods.
Latest Patents
Jan P Carisson holds a patent for a method in assaying methods involving biospecific affinity reactions. This method utilizes a component that is labeled with at least one analytically indicatable group and is soluble in the liquid where the biospecific affinity reaction occurs. The process involves the formation of an insoluble conjugate, which is then separated from the liquid phase for analysis. The analytically indicatable group is bound to the component with a splittable bond of covalent nature, allowing for effective assay methods.
Career Highlights
Carisson is associated with Pharmacia Diagnostics AB, where he has contributed to advancements in diagnostic technologies. His expertise in biospecific affinity reactions has positioned him as a key figure in the field.
Collaborations
Throughout his career, Jan P Carisson has collaborated with notable colleagues, including Rolf E Axen and Hakan N Drevin. These collaborations have further enhanced the impact of his work in the industry.
Conclusion
Jan P Carisson's innovative approach to assaying methods has paved the way for advancements in diagnostic applications. His contributions continue to influence the field and demonstrate the importance of innovation in science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.